Healthcare -
Biotechnology - NASDAQ - US
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
FOLD - PRE-TAX INCOME
Pre-tax Income FOLD - Amicus Therapeutics, Inc.
-28.8 M
LAST VALUE
65.53%
2 YEAR CAGR
39.54%
5 YEAR CAGR
8.52%
10 YEAR CAGR